site stats

Pubmed rewind

WebSep 7, 2024 · PubMed inclusion has been used, for example, as an incentive for journals to include themselves in PubMed Central, eroding the idea that PubMed is a neutral arbiter of quality. Now, a new twist is emerging, and that seems to be that PubMed may be consciously or unwittingly acting as a facilitator of predatory or unscrupulous publishing. WebMar 15, 2024 · PubMed Essentials - On Demand If you’re new to PubMed or just want a refresher, this online class is designed for you. The class is made up of 10 short units that include videos, exercises and quizzes. The class gives you the chance to explore PubMed at your own pace with guided tours and exercises. This class takes about 1 hour to complete.

Efficacy and Safety of Dulaglutide in Older Patients: A post hoc ...

WebNov 25, 2024 · Background The Researching cardiovascular Events with a Weekly INcretin in Diabetes (REWIND) double blind randomized trial demonstrated that weekly subcutaneous dulaglutide 1.5 mg, a glucagon like peptide-1 receptor agonist, versus matched placebo reduced the first outcome of major adverse cardiovascular event (MACE), cardiovascular … WebObjectives: The REWIND study sought to describe the real-world clinical and prescribing practices for the management of urinary tract infection (UTI) in Italy, Belgium, Russia and Brazil in order to compare current practices with international, European and national guidelines. Methods: An integrated mixed-methods approach was adopted that used … to the batcave meme https://corpdatas.net

Dulaglutide and cardiovascular outcomes in type 2 diabetes …

WebJul 27, 2024 · Yes. Just as the legacy site has received updates throughout its tenure, the new PubMed will continue to evolve over both the short and long term. NLM is committed to continued PubMed development, ensuring that PubMed remains a trusted and accessible source of biomedical literature today and in the future. WebJul 12, 2014 · Dulaglutide is a long-acting human GLP-1 receptor agonist ().The molecule consists of two identical, disulfide-linked chains, each containing an N-terminal GLP-1 analog sequence covalently linked to a modified human immunoglobulin G4 Fc heavy chain by a small peptide linker ().In contrast to native GLP-1, dulaglutide is resistant to … WebPubMed Central (PMC) Home Page. PubMed Central ® (PMC) is a free full-text archive of biomedical and life sciences journal literature at the U.S. National Institutes of Health's National Library of Medicine (NIH/NLM) to the basics

Dulaglutide and renal outcomes in type 2 diabetes: an exploratory ...

Category:Efficacy and Safety of Dulaglutide in Older Patients: A post

Tags:Pubmed rewind

Pubmed rewind

The effect of dulaglutide on stroke: an exploratory analysis

WebJul 19, 2024 · An initial common concern is the lack of any note taking or use of video. Practitioners are unconvinced that they will remember enough detail without the luxury of notes to refer to or a rewind button. However after just one observation we recognised the depth of observation that the method afforded. As is stated by Jackson (2008) WebMay 13, 2024 · PubMed is a free database of more than 30 million citations for published articles in the fields of biomedicine and health. PubMed includes the MEDLINE® database; citations for articles in the PubMed Central (PMC) free full text archive, including articles that report on research funded by the National Institutes of Health (NIH); and citations ...

Pubmed rewind

Did you know?

WebOct 8, 2012 · Credit: J. Player/Rex Features; Aflo/Rex Features. The discovery that cells can be reprogrammed to an embryonic-like state has won this year’s Nobel Prize in Physiology or Medicine for two ... WebIn the REWIND trial, dulaglutide reduced cardiovascular (CV) risk versus placebo in patients with type 2 diabetes in both the "established CV disease" (CVD) and "CV risk factor" subgroups. The SUSTAIN 6 and PIONEER 6 trials of semaglutide used different criteria for established CVD from those used in REWIND. The present post hoc analysis assessed the …

WebMay 12, 2024 · The new PubMed features a modern interface with enhanced search results, including highlighted text snippets to help you preview an abstract while scanning your results list, and updated web elements for easier navigation. The new Best Match sort order uses advanced machine-learning technology and a new relevance search algorithm to … WebSep 1, 2024 · Article CAS PubMed PubMed Central Google Scholar Molina-Arcas M, Moore C, Rana S, van Maldegem F, Mugarza E, Romero-Clavijo P, et al. Development of combination therapies to maximize the impact of ...

WebFeb 4, 2024 · The present post hoc analysis of REWIND evaluated the CV efficacy and safety of dulaglutide vs placebo by age subgroups (≥ 65 and < 65 years) in this larger and longer-duration, randomized controlled trial. Materials and Methods Study Design and Patients. The study design of the REWIND trial was previously published (7, 9). WebJustice reinvestment was introduced as a response to mass incarceration and racial disparity in the United States in 2003. This book examines justice reinvestment from its origins, its potential as a mechanism for winding back imprisonment rates, and its portability to Australia, the United Kingdom and beyond. The authors analyze the principles ...

WebJan 28, 2024 · The Rewind Technique is a non-pharmacological reconsolidation-based therapy with promising early results, which now requires evaluation through an RCT. Objectives: This is a preliminary efficacy RCT to determine if the Rewind Technique is likely to be a good candidate to test against usual care in a future pragmatic efficacy RCT.

WebSep 22, 2024 · PubMed is a free search engine accessing primarily the MEDLINE database of references and abstracts on life sciences and biomedical topics. Available to the public online since 1996, PubMed was developed and is maintained by the National Center for Biotechnology Information (NCBI) , at the U.S. National Library of Medicine (NLM) , … potassium charge chemistryWebREWIND TECHNIQUE, EXTINCTION, RECONSOLIDATION Introduction The visual-kinesthetic dissociation (V/KD) protocol (as discussed below) is an intervention originally designed in the early 1980s for use with phobias. The protocol is one of many anecdotally supported interventions that emerges from the fi eld of neuro-linguistic programming (NLP). to the batcave soundWebOut of six patients (five female, one male) with a median age of 72 (range 58-79), four were related to smoking, and two due to lighting candles. The mean total body surface area (TBSA) affected was 17% (range 2-60%). Five patients sustained facial burns, two suffered from inhalation injury (33.3%), and five required surgery (83.3%). to the batcave robinWebDulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial. Prof Hertzel C Gerstein, MD . Hertzel C Gerstein. Correspondence. Correspondence to: Prof Hertzel C Gerstein, Population Health Research Institute, McMaster University and Hamilton Health Sciences, Hamilton, ON, L8S 4K1, … potassium charts to printWebJan 16, 2024 · Tip: PubMed is a great interface for carrying out a basic scoping search, or if you wish to identify a limited number of key references. MEDLINE via Ovid is recommended if you wish to carry out a comprehensive, structured or systematic search . The Ovid interface provides access to a range of databases, e-journals and e- books. What is … potassium chelated douglas labsWebJun 10, 2024 · Methods. REWIND was a multicentre, randomised, double-blind, placebo-controlled trial at 371 sites in 24 countries. Men and women aged at least 50 years with type 2 diabetes who had either a previous cardiovascular event or cardiovascular risk factors were randomly assigned (1:1) to either weekly subcutaneous injection of dulaglutide (1·5 … potassium chelating agentWebMethods: REWIND was a multicentre, randomised, double-blind, placebo-controlled trial done at 371 sites in 24 countries. Men and women (aged ≥50 years) with established or newly detected type 2 diabetes whose HbA 1c was 9·5% or less (with no lower limit) on stable doses of up to two oral glucose-lowering drugs with or without basal insulin therapy were … to the batcave sound effect